Leukemia Myeloid Acute

• EMA withdrawal · 2021-08-04
  EMA Withdrawn: Azacitidine Celgene (azacitidine) — Celgene Europe BV

  The EMA has withdrawn the azacitidine product Celgene Europe BV from the market.

• EMA withdrawal · 2020-02-07
  EMA Application withdrawn: Idhifa — Celgene Europe BV

  EMA withdrawn the application for Idhifa (benzenedicarboxamide?) by Celgene Europe BV; therapeutic area Leukemia, Myeloid, Acute.